HOME >> BIOLOGY >> NEWS
Scientists Urge Further Study Of Alarming Coral Reef Decline

Scientists are becoming increasingly concerned about the mysterious decline of coral reefs throughout the world and are recommending more extensive research into the potentially serious problem.

The corals are at the center of a complex food web. When they die, thousands of other species are in jeopardy. People in some developing nations are dependant on the coral reef communities for their food or livelihoods. Corals also contain toxins that offer promise for cancer research and chemical compounds that could be used to make new medicines. "But we are just in the infancy of doing those kinds of studies," said Johns Hopkins University biologist Gary K. Ostrander. Ostrander co-authored a scientific paper about the worldwide threat with biologist William J. Meehan, a doctoral student in his laboratory.

The paper, essentially an overview of declining coral reef health, will be published on April 25 in the Journal of Toxicology and Environmental Health.

"We are pointing out that these corals are dying all over the world," Ostrander said. Scientists do not know what is causing the coral reef deterioration, which has accelerated dramatically since the early 1980s. But their deaths may signal serious, as-yet unidentified environmental ills, said Ostrander, who noted in the paper that there have been few studies to detail the phenomenon at the molecular and cellular levels. Also lacking are studies aimed at uncovering possible environmental causes.

"We believe our ability to understand and possibly remedy this complex global problem will be accelerated as toxicologists begin to address these issues," the two biologists concluded in their paper.

Corals, like jellyfish and sea anemones, belong to the phylum Cnidaria. They are tiny animals that use their tentacles to catch food particles floating in the water. Certain types of corals produce calcium carbonate skeletons -- the coral reefs. Once attached to the chalky white skeleto
'"/>

Contact: Emil Venere
Emil@jhu.edu
410-516-7160
Johns Hopkins University
2-Apr-1997


Page: 1 2 3

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientists Urge Further Study Alarming Coral Reef Decline

(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: